The Effect of Treatment with an LH-RH Agonist (Buserelin) on Gonadal Activity, Growth, and Bone Maturation in Children with Central Precocious Puberty

    May 1987 in “ European Journal of Pediatrics ”
    Stenvert L. S. Drop, Roelof J. Odink, C. Rouwé … M. Meradji
    Studysummary This study concluded that Buserelin can effectively inhibit gonadal activity in children with central precocious puberty over 18 months, potentially improving final height predictions with prolonged treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →